FDA 510(k)

SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System

K-Number: K170191 · 2017-06-16

Decision Date2017-06-16

Product CodeMCW

Advisory CommitteeCV

DecisionSubstantially Equivalent

Device Summary

SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Vascular, Inc.. It received FDA 510(k) clearance on 2017-06-16 under 510(k) number K170191. The device is classified under product code MCW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System?

SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System is a medical device that received FDA 510(k) clearance on 2017-06-16. The listed applicant is Medtronic Vascular, Inc.. The 510(k) number is K170191.

When did SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System receive FDA 510(k) clearance?

SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System received FDA 510(k) clearance on 2017-06-16, under 510(k) number K170191.

Who is the listed applicant for SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System?

The FDA 510(k) record lists Medtronic Vascular, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System?

The FDA product code for SilverHawk Peripheral Plaque Excision System, TurboHawk Peripheral Plaque Excision System is MCW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT02439775SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation SystemCOMPLETED NCT05198674SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNACTIVE_NOT_RECRUITING NCT06907147SPYRAL GEMINI Pilot StudyRECRUITING NCT07115953Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled HypertensionRECRUITING

Other records listing Medtronic Vascular, Inc. as applicant

PMA P160043Coronary drug-eluting stent PMA P110023STENT, SUPERFICIAL FEMORAL ARTERY PMA P060001Stent, carotid PMA P190008Drug-coated peripheral transluminal angioplasty catheter PMA P100021SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT PMA P200026Stent, iliac vein

View all 28 devices →

Related Devices (Code: MCW)

K260244Auryon Atherectomy SystemEximo Medical K250723FreedomFlow™ Orbital Circumferential Atherectomy System (H6005/ 4Fr 3-Sphere Configuration)Cardio Flow Inc.,K250385Turbo-Elite Laser Atherectomy CatheterSpectranetics K242757Rotarex Atherectomy SystemBard Peripheral Vascular, Inc.K242947FreedomFlow™ Orbital Circumferential Atherectomy SystemCardio Flow Inc.,K241553Auryon Atherectomy Catheter 1.7mm; Auryon Atherectomy Catheter 1.7mm, Hydrophilic CoatingEximo Medical, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.